| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |